<SEC-DOCUMENT>0001104659-17-054979-index.html : 20170831 <SEC-HEADER>0001104659-17-054979.hdr.sgml : 20170831 <ACCEPTANCE-DATETIME>20170831172208 ACCESSION NUMBER: 0001104659-17-054979 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20170831 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170831 DATE AS OF CHANGE: 20170831 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 171064003 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a17-21218_18k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a17-21218_18k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>a17-21218_1ex10d1.htm <DESCRIPTION>EX-10.1 <TEXT> Document 2 - file: a17-21218_1ex10d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>a17-21218_1ex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 3 - file: a17-21218_1ex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g212181mmi001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g212181mmi001.jpg
</DOCUMENT> </SEC-DOCUMENT>